| 标题 |
 Abstract 4139206: Design of Heart-2: a phase 1b clinical trial of VERVE-102, an in vivo base editing medicine delivered by a GalNAc-LNP and targeting PCSK9 to durably lower LDL cholesterol |
| 网址 | |
| DOI | |
| 其它 |
期刊：Circulation 作者：Scott Vafai; Verena Karsten; Chelsey Jensen; Richard Falzone; Troy Lister; et al 出版日期：2024 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
cdercder
大力的冬萱
ale
Copyright
认真的不评
Nexus
yjh123
arniu2008
俊秀的白曼
关山北
行走的荷尔蒙
Nole
可靠的南露
殷勤的紫槐
dawd
aaaa
蓝天
sagitar
挖掘机
皖公网安备34019202002308
